Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > Not if, but becoming more mainstream...building forward
View:
Post by FactFinder1994 on May 29, 2023 2:31pm

Not if, but becoming more mainstream...building forward

 
  • Ex-vivo lung perfusion (EVLP110) is a novel technique invented at the University Health Network by a team led by Dr. Shaf Keshavjee and Dr. Marcelo Cypel. This approach to lung perfusion has revolutionized organ transplantation. As the procedure becomes more mainstream in complex surgical facilities, the need to build capacity in the health care system to provide care in this way is increasingly important. Led by an expert faculty of international recognition, the Michener Institute of Education at UHN is excited to partner with UHN and members of the University of Toronto Department of Surgery to host this first-of-its kind course.
  • Review the use of biomarkers during ex vivo lung perfusion (Assessment of the Inclusion of Biomarker Scoring in EVLP Decision-Making)
Outline & Format

Ex-vivo Lung Perfusion (EVLP110) - The Michener InstituteMichener Institutehttps://michener.ca › Continuing Education Courses

So much hapening behind the scenes - incredible market created for SQI.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities